Drew Spaventa

We are the pioneers of genomics enabled precision medicine. Our journey begins in the NICU, with exciting opportunities to address broader needs on the horizon.

Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD) and extending across the brain and affected organs.

Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Our vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy. The “Big Data” Problem: As DNA sequencing costs have plummeted over the last few years, furthered by Illumina’s recent announcement of the ability to sequence genomes for below $1,000, raw data generated by sequencing has increased exponentially, measuring petabytes of data, making analyses and transfer of all this data difficult. These large amounts of data produce a critical bottleneck in the DNA sequencing workflow that has previously only been addressable by throwing increasing numbers of ever more powerful CPU cores at the problem. However, since the data being produced by sequencing already far outpaces Moore’s Law, this solution has very limited sustainability. DRAGEN™ Bio-IT Processor To address this problem, Edico Genome is developing the DRAGEN™ Bio-IT Processor, the world’s first Next Generation Sequencing (NGS) bioinformatics reconfigurable processor. It enables the computational time required for the NGS data analysis pipeline to be radically reduced from many hours down to only a few minutes. The mapping, alignment, sorting and variant calling that is currently performed by software on extensive cluster or cloud-based platforms, is performed at a fraction of the computing cost by DRAGEN - without compromising accuracy. Our patent-pending technology makes it faster, easier and cheaper to work with NGS data and to discover links between DNA sequence variations and human disease.

Headquartered in San Diego, California, ecoATM is the pioneer in device re-Commerce. We offer a broad network of eco-friendly automated kiosks that provide instant payment and responsible recycling for electronic devices. ecoATM kiosks, through its secure technology, provide a safe and convenient way for consumers to recycle pre-owned electronic devices across a range of manufacturers, conditions and values. We work closely with our customers to create a rewarding experience that is financially and environmentally beneficial. We’re here to change how the world thinks about pre-owned consumer technology and make a lasting, positive impact globally.

We are the pioneers of genomics enabled precision medicine. Our journey begins in the NICU, with exciting opportunities to address broader needs on the horizon.

Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD) and extending across the brain and affected organs.

Connect w/ San Diego Venture Group helps to grow and fund great innovation companies.

Singular Genomics is inventing at the forefront of genomics, one of the world’s fastest-growing industries. We are a publicly traded life science technology company that is leveraging novel, next-generation sequencing (NGS) and multi-omics technologies to build products that empower researchers and clinicians. The G4 Sequencing Platform, our first commercially available product, is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. We are committed to unlocking the potential of our core technologies to reshape the future of genomics. We offer a dynamic, fast-paced, results-oriented environment where employees can make a significant impact in a rapidly expanding company. Innovation, continuous learning, multi-disciplinary collaboration, and diversity of thought are pillars of our culture.